Skip to main navigation

Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Events and Presentations

Events and Presentations

Presentations

September 6, 2022

Corporate Presentation September 2022

Asset Categories

Investor Presentation

Past Events

March 2, 2022

Oral Small Molecule Hepatocyte Growth Factor/MET Positive Modulator ATH-1020 Reduces Depression-like Behaviors and Normalizes Pathological EEG Mismatch Negativity in Preclinical Models

Scientific Presentation

November 18, 2021 at 4:00 AM EST

Jefferies London Healthcare Conference

Investor Presentation

November 15, 2021 at 2:40 PM EST

Stifel’s 2021 Virtual Healthcare Conference

Investor Presentation

November 10, 2021 at 11:50 AM EST

Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Scientific Presentation

November 5, 2021 at 12:00 PM EDT

Educational Webinar on the Clinical Applications of ERP P300

Scientific Presentation

October 21, 2021 at 4:30 PM EDT

Athira Corporate Update

Investor Presentation

Pagination

First page
Previous page
Page 1
Current page 2

SIGN UP FOR EMAIL ALERTS

CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

© Athira Pharma, Inc. All rights reserved.